Coronary artery disease

Area of Science:

• Cardiology and Nephrology
• Cardiovascular Disease in Chronic Kidney Disease

Background:

• Coronary heart disease (CHD) is the primary cause of mortality in both the general population and patients with end-stage renal disease (ESRD).
• Established principles of cardiovascular risk assessment and management are applicable to ESRD patients, though unique considerations exist.
• Noninvasive coronary artery imaging advancements aid in the early detection of subclinical CHD.

Purpose of the Study:

• To explore clinical issues surrounding coronary artery disease (CAD) in patients with ESRD.
• To discuss the distinct risk-benefit profiles of coronary revascularization strategies in the ESRD population.
• To review optimal management approaches for stable CAD and acute coronary syndromes (ACS) in ESRD.

Main Methods:

• Review of current literature and clinical guidelines regarding CHD in ESRD.
• Analysis of outcomes associated with different revascularization techniques (coronary artery bypass grafting vs. percutaneous coronary intervention).
• Exploration of risk factors and management principles specific to ESRD patients with CAD.

Main Results:

• Coronary artery bypass surgery is often favored for stable ESRD patients with multivessel CAD, despite inherent risks like stroke and infection.
• Percutaneous coronary intervention on the target vessel demonstrates the most favorable outcomes for ESRD patients experiencing acute coronary syndromes.
• Medical management aims to modify disease progression and alleviate angina symptoms.

Conclusions:

• Management of coronary artery disease in ESRD requires careful consideration of patient-specific factors and procedural risks.
• Revascularization strategies must be tailored based on disease presentation (stable vs. acute) to optimize outcomes in ESRD.
• Further research is warranted to refine treatment protocols for this high-risk population.